AGRP and metabolic syndrome: In patients with MetS, there is an increase in the circulating levels of the anorexigenic hormone leptin, produced by the adipose tissue; however, due to leptin resistance, the inhibitory effect of leptin on neurons, expressing neuropeptide Y and agouti-related protein (AgRP), does not occur, thus resulting in an increased hunger stimulation response.